Zubeir Nurgat

King Faisal Specialist Hospital & Research Centre

Papers

2

Total Citations

46

H-Index

2

About

Zubeir Nurgat is a leading expert in the automation of sterile compounding, with a focused research program dedicated to evaluating the safety, efficiency, and operational impact of robotic systems in hospital pharmacies. His seminal work, "A three-year study of a first-generation chemotherapy-compounding robot" (2015, 39 citations), provides a landmark, longitudinal performance evaluation of the CytoCare robot in Saudi Arabia, demonstrating its reliability for preparing hazardous antineoplastic drugs. This study is foundational for institutions considering robotic adoption, offering critical data on error rates, workflow integration, and long-term operational outcomes. Nurgat further advanced the field with his 2019 study on a standalone robotic device for batch compounding of small-volume parenterals (7 citations), which quantified reductions in drug waste and improvements in aseptic technique. His contributions are pivotal in shifting pharmacy practice from manual, high-risk processes to automated, auditable systems that enhance patient safety and staff protection. Through these rigorous, real-world assessments, Nurgat has established himself as a key authority on the practical implementation and measurable benefits of pharmacy robotics.

Research Focus

Key Achievements

2
H-Index
2
Papers
46
Total Citations
23
Avg Citations/Paper
🏆 Most Cited Paper
A three-year study of a first-generation chemotherapy-compounding robot
39 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: King Faisal Specialist Hospital & Research Centre

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago